You've used all available free searches this month | for more free features.
Clincosm LogoSign in Get a demo

intermediate-1 risk myelodysplastic syndromes

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome Trial in Chicago (Laboratory Biomarker

Completed
  • Acute Myeloid Leukemia
  • +4 more
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
May 12, 2021

Lower Risk MDS Per IPSS-R Trial (Luspatercept)

Not yet recruiting
  • Lower Risk MDS Per IPSS-R
  • (no location specified)
Jun 21, 2023

MDS, Thrombocytopenia Trial in Worldwide (Eltrombopag/Revolade, Placebo)

Active, not recruiting
  • Myelodysplastic Syndromes
  • Thrombocytopenia
  • Amiens, France
  • +63 more
Jan 13, 2022

MDS Trial run by the National Cancer Institute (NCI) (KPT-8602, Inqovi)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 30, 2023

MDS Trial in Houston (Luspatercept)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Houston, Texas
    M D Anderson Cancer Center
Nov 2, 2023

Acute Myeloid Leukemia, in Relapse, MDS Trial in Australia, United States (CB-5339)

Recruiting
  • Acute Myeloid Leukemia, in Relapse
  • Myelodysplastic Syndromes
  • Scottsdale, Arizona
  • +8 more
May 17, 2021

Acute Myeloid Leukemia, MDS Trial in Rochester, Houston (CTX-712)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Rochester, Minnesota
  • +1 more
Feb 15, 2023

Leukemia Trial in Houston (Decitabine, Azacitidine)

Completed
Has Results
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 1, 2020

MDS Trial in France, Germany (N-Plate / romiplostim)

Completed
  • Myelodysplastic Syndromes
  • N-Plate / romiplostim
  • Annecy, France
  • +35 more
Sep 7, 2021

MDS Trial in Worldwide (MBG453, NIS793, canakinumab)

Recruiting
  • Myelodysplastic Syndromes
  • Duarte, California
  • +14 more
Jan 23, 2023

MDS Trial in France (transplantation)

Active, not recruiting
  • MDS
  • transplantation
  • Amiens, France
  • +36 more
Jul 4, 2022

Acute Myeloid Leukemia, MDS Trial in United States (GLB-001)

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Duarte, California
  • +3 more
Nov 21, 2023

MDS Trial in China, Japan (Luspatercept)

Recruiting
  • Myelodysplastic Syndromes
  • Beijing, China
  • +33 more
Aug 16, 2022

Low Risk MDS Trial (R906289 Monosodium (R289 Na))

Not yet recruiting
  • Low Risk Myelodysplastic Syndromes
  • R906289 Monosodium (R289 Na)
  • (no location specified)
Jul 22, 2022

Untreated Myelodysplastic Syndrome Trial in France (Onureg + Venetoclax)

Not yet recruiting
  • Untreated Myelodysplastic Syndrome
  • Onureg + Venetoclax
  • Angers, France
  • +9 more
Mar 13, 2023

Allogeneic Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Suzhou

Recruiting
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +2 more
  • VEN+AZA+Modified BUCY
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Apr 10, 2023

Low/Intermediate Risk-1 MDS Trial in Beijing (Danazol + rhTPO (recombinant human thrombopoietin injection), Danazol + sodium

Active, not recruiting
  • Low/Intermediate Risk-1 MDS
  • Danazol + rhTPO (recombinant human thrombopoietin injection)
  • Danazol + sodium chloride
  • Beijing, China
    Peking union medical college hospital
Mar 26, 2020

Myelodysplastic Syndrome Trial in France, Germany, Spain (Lenalidomide, Placebo)

Active, not recruiting
  • Myelodysplastic Syndrome
  • Strasbourg, Bajo Rin, France
  • +24 more
Nov 22, 2021

MDS Trial in Seoul (cyclophosphamide, fludarabine, and antithymocyte globulin)

Active, not recruiting
  • Myelodysplastic Syndromes
  • cyclophosphamide, fludarabine, and antithymocyte globulin
  • Seoul, Korea, Republic of
    Asan Medical Center, University of Ulsan College of Medicine
Oct 19, 2023

Acute Myeloid Leukemia, High-Risk and Very High-Risk MDS Trial (SGR-2921)

Not yet recruiting
  • Acute Myeloid Leukemia
  • High-Risk and Very High-Risk Myelodysplastic Syndromes
  • (no location specified)
Jul 25, 2023

MDS, CMML, AML Trial in Canada, United States (SGI-110)

Completed
  • MDS
  • +2 more
  • Scottsdale, Arizona
  • +15 more
Apr 16, 2021

Strategy for High-Risk Myelodysplastic Syndromes in Patients

Active, not recruiting
  • Myelodysplastic Syndromes
  • Allogeneic Stem Cell Transplantation
  • Agen, France
  • +9 more
Jul 5, 2022

Mean Platelet Volume and Its Relation to Risk Stratification of

Completed
  • Myelodysplastic Syndromes
    • (no location specified)
    Jan 21, 2022

    MDS, Anemia Trial in Germany (Luspatercept Injection)

    Recruiting
    • Myelodysplastic Syndromes
    • Anemia
    • Luspatercept Injection
    • Berlin, Germany
    • +18 more
    Jan 25, 2023

    MDS, Ferroptosis Trial in Pessac (Biological sampling)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • Ferroptosis
    • Biological sampling
    • Pessac, France
    • +2 more
    Jun 19, 2023